BioChemics, Inc. Awarded Patent for Development of Bifunctional Synthetic Molecules – A Novel Drug Delivery And Efficacy Enhancement Technology
1/30/2013 9:41:45 AM
More...
|
Wound Healing and Inflammation Patent Issued to BioChemics, Inc.
1/17/2013 9:20:22 AM
More...
|
BioChemics, Inc. Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Osteoarthritis
12/8/2011 7:16:54 AM
More...
|
BioChemics, Inc. Announces Collaboration Agreement with Unilever (UN)
10/5/2009 9:56:07 AM
More...
|
BioChemics, Inc. to Present at Second Annual Boston Biotech R&D Conference
10/1/2009 8:57:19 AM
More...
|
BioChemics, Inc. Announces Collaboration Agreement with Pacific Pharmaceuticals (PHA)
8/5/2009 8:46:51 AM
More...
|
BioChemics, Inc. Announces Expanded Scope of Collaboration with a Leading Light Based Technology Company
6/3/2009 8:59:23 AM
More...
|
BioChemics, Inc. Announces Collaboration Agreement with Leading Light Based Technology Company
9/30/2008 8:37:19 AM
More...
|
Dr. R. Rox Anderson Joins BioChemics, Inc. Scientific Advisory Board to Advise on Development of Dermatological Products
6/3/2008 9:56:50 AM
More...
|
Dr. Roy Altman Joins BioChemics, Inc. Scientific Advisory Board to Advise on Clinical Development of Targeted Osteoarthritis Therapy
5/7/2008 11:15:22 AM
More...
|
|